Each year approximately 225,000 people will be diagnosed with lung cancer. Each year approximately 50,000 of all new cases will be adults under the age of 40. The 5-year survival rate is around 17%. More than half of patients with lung cancer will die within a year of diagnosis.

Our Partners


Uniting Against Lung Cancer (UALC) is dedicated to funding innovative research and raising awareness to find a cure for lung cancer.

UALC is funding lung cancer research with the potential to make a significant impact on treatment and a cure. Since 2003, UALC has awarded over $11.5 million to academic investigators, leading to over $55 million in follow-on funding, new researchers entering the field, and scientific progress that is already impacting lung cancer patients. Guided by a renowned Medical Committee, UALC is funding research that makes a difference.


Uniting Against Lung Cancer is a tax exempt 501(c)(3) nonprofit corporation with the EIN 13 419 5464.
Uniting Against Lung Cancer: 27 Union Square West, Suite 304, New York, NY 10003
Tel: 212.627.5500/Email: mail@unitingagainstlungcancer.org